Novabay Pharmaceuticals (NBY)
NYSE MKT:NBY
Holding NBY?
Track your performance easily

NovaBay Pharma (NBY) Financial Statements

623 Followers

NovaBay Pharma Financial Overview

NovaBay Pharma's market cap is currently ―. The company's EPS TTM is $-47.977; its P/E ratio is >-0.01; NovaBay Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.40M$ 2.63M$ 3.73M$ 3.27M$ 4.60M
Gross Profit$ 1.59M$ 1.79M$ 1.81M$ 1.84M$ 2.31M
EBIT$ -1.58M$ -3.21M$ -798.00K$ -1.76M$ -2.04M
EBITDA$ -1.09M$ -2.79M$ -748.00K$ -1.04M$ -1.53M
Net Income Common Stockholders$ -1.58M$ -3.59M$ -9.17M$ -1.76M$ -4.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 751.00K$ 1.82M$ 3.13M$ 3.47M$ 4.41M
Total Assets$ 3.92M$ 5.36M$ 9.03M$ 12.85M$ 16.01M
Total Debt$ 2.01M$ 2.42M$ 2.74M$ 3.00M$ 3.04M
Net Debt$ 1.26M$ 600.00K$ -390.00K$ -473.00K$ -1.37M
Total Liabilities$ 4.54M$ 5.20M$ 5.72M$ 5.82M$ 7.45M
Stockholders Equity$ -617.00K$ -1.28M$ 3.31M$ 7.04M$ 8.56M
Cash Flow-
Free Cash Flow$ -580.00K$ -1.57M$ -316.00K$ -365.00K$ -1.83M
Operating Cash Flow$ -578.00K$ -1.57M$ -314.00K$ -363.00K$ -1.83M
Investing Cash Flow$ -2.00K$ 1.07M$ -2.00K$ -2.00K$ -2.00K
Financing Cash Flow$ -492.00K$ -597.00K$ -26.00K$ -577.00K$ 2.51M
Currency in USD

NovaBay Pharma Earnings and Revenue History

NovaBay Pharma Debt to Assets

NovaBay Pharma Cash Flow

NovaBay Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis